Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03512249 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 30, 2018
Last Update Posted : February 22, 2024
|
Sponsor:
International AIDS Vaccine Initiative
Collaborators:
Statens Serum Institut
South African Tuberculosis Vaccine Initiative
University of Cape Town Lung Institute
TASK Applied Science
The Aurum Institute NPC
National Institute for Medical Research, Tanzania
Ospedale San Raffaele
European and Developing Countries Clinical Trials Partnership (EDCTP)
Information provided by (Responsible Party):
International AIDS Vaccine Initiative
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | March 20, 2023 |
| Estimated Study Completion Date : | March 30, 2024 |